http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0112194-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0264ab149dd139d522f7f14b1a3ea9e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ffcf542960ce9ccdadf3d0d87b2fe72f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_90e2da1961eb4c59c9d30719a8deefd2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2e3194624e93993124d9a41f76231b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c844726d7b2a41ca1511010e7a0483c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
filingDate 2000-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e96238c8c5b96d96a4a00242e61a03a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d4be77a71bd622674a6408ab2584afa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7be8e5dca659337a28ca2e10e1efe3dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a762736bf222a391accc7c122c685e69
publicationDate 2001-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0112194-A1
titleOfInvention Combinations with antithrombotic activity consisting of clopidogrel hydrogenosulphate and a gpiib/iiia receptor antagonist
abstract The invention concerns a combination with antithrombotic activity of two antiaggregating active principles, consisting of clopidogrel hydrogenosulphate and an antagonist of the fibrinogen GPIIb/IIIa receptors (anti-GPIIb/IIIa).
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005070464-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005070464-A2
priorityDate 1999-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5607952-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9809629-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9729753-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4737
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60947
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7371
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5472
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID230573281
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394941
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136197710
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128918298
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395812
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6022
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID643985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69136325
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3108
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128241576
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396699
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127968075
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406337
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393245
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412544
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9861403
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396248
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID244265851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396698
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413167

Total number of triples: 53.